Study identifier:D6874L00016
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Oral mucosal absorption study of ICI176,334-1 (Bicalutamide new formulation) in Japanese healthy male subjects
Healthy
Phase 1
Yes
ICI176,334-1
Male
8
Interventional
20 Years - 45 Years
Allocation: Non-randomized
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: Active 1 8 subjects will receive ICI176,334-1 | Drug: ICI176,334-1 Subject will receive single dose of ICI176,334-1 |